Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 850 of 1294 entries
View as:

A Research Study Comparing a New Medicine Oral Semaglutide to Placebo in People With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT04109547 Org: User:
Start: 10/01/19 End: 10/27/21 Due: 10/27/22

A Trial Comparing the Pharmacokinetic Properties of Faster-acting Insulin Aspart (FIAsp) After Different Injection Regions and Routes of Administration in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02089451 Org: User:
Start: 03/17/14 End: 06/06/14 Due: 06/06/15

Bioequivalence of Two Liraglutide Formulations in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01515553 Org: User:
Start: 01/31/07 End: 04/30/07 Due: 04/30/08

Observational Study to Assess the Quality of Life and Clinical Outcomes in Subjects Using NovoMix® 30 for the Treatment of Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00696163 Org: User:
Start: 04/30/08 End: 03/31/09 Due: 03/31/10

Survey Evaluating the Psychosocial Effects of Living With Haemophilia

Phase: N/A Priority: Normal
NCT ID: NCT01322620 Org: User:
Start: 06/03/11 End: 02/29/12 Due: 02/28/13

Safety and Tolerability of Anti-IL-20 in Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01038674 Org: User:
Start: 02/28/10 End: 12/31/10 Due: 12/31/11

Research Study to Compare Semaglutide Tablets With Empagliflozin or Metformin Tablets in People With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT06083675 Org: User:
Start: 01/26/24 End: 05/28/27 Due: 05/28/28

A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03914326 Org: User:
Start: 06/17/19 End: 08/23/24 Due: 08/23/25

Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00598793 Org: User:
Start: 11/30/02 End: 03/31/04 Due: 03/31/05

Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00569400 Org: User:
Start: 05/01/03 End: 01/19/04 Due: 01/19/05

Regulatory Post Marketing Surveillance (rPMS) Study of Ozempic (Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea

Phase: N/A Priority: Normal
NCT ID: NCT05689372 Org: User:
Start: 03/31/25 End: 11/30/26 Due: 11/30/27

Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin

Phase: N/A Priority: Normal
NCT ID: NCT01907854 Org: User:
Start: 12/02/13 End: 06/15/15 Due: 06/15/16

Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00184613 Org: User:
Start: 05/31/05 End: 01/31/06 Due: 01/31/07

Post-Marketing Surveillance (Special Use-results Surveillance on Long-term Use) With Sogroya®

Phase: N/A Priority: Normal
NCT ID: NCT05230550 Org: User:
Start: 02/03/22 End: 12/31/26 Due: 12/31/27

A Single Dose Trial of Recombinant Factor VIII (N8) in Japanese Subjects With Haemophilia A: An Extension to Trial NN7008-3543

Phase: N/A Priority: Normal
NCT ID: NCT01238367 Org: User:
Start: 11/30/10 End: 10/31/11 Due: 10/31/12

Investigating the Influence of Omeprazole on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02249871 Org: User:
Start: 09/24/14 End: 04/01/15 Due: 04/01/16

A Multiple Dose Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01796366 Org: User:
Start: 02/21/13 End: 08/19/13 Due: 08/19/14

Efficacy and Safety of Repaglinide and Metformin Combination Therapy in Type 2 Diabetes Failing on Oral Anti-diabetic Drugs

Phase: N/A Priority: Normal
NCT ID: NCT00491725 Org: User:
Start: 09/30/05 End: 06/30/06 Due: 06/30/07

A Research Study of a New Medicine NNC0519-0130 in Healthy People, People With High Body Weight and People With Type 2 Diabetes.

Phase: N/A Priority: Normal
NCT ID: NCT05363774 Org: User:
Start: 04/20/22 End: 04/02/24 Due: 04/02/25

Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02863419 Org: User:
Start: 08/10/16 End: 03/30/18 Due: 03/30/19

Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00504673 Org: User:
Start: 04/30/05 End: 12/31/06 Due: 12/31/07

Safety and Tolerability of Liraglutide in Japanese Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01615978 Org: User:
Start: 12/31/03 End: 03/31/04 Due: 03/31/05

Treatment of Congenital Factor VII Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT01779921 Org: User:
Start: 10/31/05 End: 01/31/12 Due: 01/31/13

Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children

Phase: N/A Priority: Normal
NCT ID: NCT00102817 Org: User:
Start: 05/31/03 End: 12/31/06 Due: 12/31/07

Observational Study on Safety of Self-titration of Once Daily Levemir®

Phase: N/A Priority: Normal
NCT ID: NCT00740519 Org: User:
Start: 09/30/08 End: 03/31/11 Due: 03/31/12